ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)

ACC.21 Congress (American College of Cardiology 2021 Congress)

• From May 15 – 17, ACC.21 streamed to thousands of members of the cardiovascular team from around the world! Take time to explore ALL the education from ACC.21 with On Demand access.
• Watch 300+ sessions featuring practice-changing research and cutting-edge education. Plus, don’t miss the more than 3,3000 eAbstracts, 100+ exhibitors, and the opportunity to celebrate the achievements of our colleagues with Convocation. Sample from an unparalleled array of education when it’s convenient for you — from your home, office, or on-the-go — across 11 learning pathways. ACC.21 will leave you up to date on the newest clinical research and you’ll find out how it all impacts the care of your patients.

*Contents: (297 videos)

• | 406 Joint American College of CardiologyJournal of the American Medical Association Late-Breaking Clinical Trials.ts
• | 407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts
• | 411 Late-Breaking Clinical Trials V.ts
• | 908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts
• | 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts
• | A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts
• | A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts
• | A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts
• | A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts
• | ACC Cardiology Hour.ts
• | ACC.21 Highlights in Hypertension.ts
• | ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf
• | Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts
• | Adult Congenital Heart Disease Cases That Stumped Me.ts
• | Advanced Nuclear Cardiology Applications in 2021.ts
• | Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts
• | Advancing Patient Care Across the Heart Failure Continuum.ts
• | Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts
• | Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4
• | Antithrombotic Controversies in the Cath Lab.ts
• | Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts
• | Aortic Valve Interventions Clinical Dilemmas.ts
• | Aortic Valve Interventions Expanding Indications.ts
• | Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts
• | Applying the Guidelines For Lipid Management in Special Populations.ts
• | Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts
• | ASCVD Risk Factors and Beyond.ts
• | Atrial Fibrillation Management in Athletes.ts
• | Best of JACC Journals & Eugene Braunwald Keynote.ts
• | Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts
• | Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts
• | Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts
• | Bleeding Reduction Strategies Following PCI.ts
• | Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts
• | Cardiac CT in Clinical Practice.ts
• | Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts
• | Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts
• | Cardiac Point of Care Ultrasound Around the World.ts
• | Cardiac Rehab Move to Improve.ts
• | Cardio-Oncology Today’s Standard of Practice.ts
• | Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts
• | Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts
• | Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts
• | Cardiovascular Considerations in Amateur and Professional Athletes.ts
• | Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts
• | Cardiovascular Imaging to Enhance Prevention.ts
• | Caring for the Patient with STEMI in 2021.ts
• | Case Based Learning for the Cardiovascular Team.ts
• | Cases from the Guidelines for Clinicians.ts
• | CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts
• | Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy & MCS.ts
• | Challenging Cases in Cardio-Oncology.ts
• | Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts
• | Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts
• | Clinical Trials Research Upping Your Game.ts
• | Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts
• | Complex and High-Risk PCI Case Based Joint Symposium.ts
• | Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts
• | Complex Dilemmas in Valvular Heart Disease.ts
• | Contemporary Aortic Valve Disease Management.ts
• | Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts
• | Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts
• | Controversies in Arrhythmia Therapy.ts
• | Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts
• | Controversies in the ICU Management of Congenital Heart Disease.ts
• | Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts
• | Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts
• | Core Knowledge in Action The Ultimate Guide to Lipids.ts
• | Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts
• | Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts
• | Coronary IVL’s Who, What, Where, When & Why An Introductory Guide for Clinical Practice.ts
• | COVID 19 and Heart Failure Lessons Learned and Future Directions.ts
• | COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts
• | Critical Clinical Conundrums in Acute Coronary Syndromes.ts
• | Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts
• | Current Controversies And Debates in CAD Imaging.ts
• | CVD Prevention in the Post-COVID19 Era2.ts
• | Debates in Arrhythmia Management in Congenital Heart Disease.ts
• | Debates Should We Tailor Antiplatelet Therapy for PCI.ts
• | Debating Controversies in STEMI Care.ts
• | Deep Dive I.ts
• | Deep Dive II.ts
• | Destined to Fail How to Prevent Heart Failure.ts
• | Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts
• | Diabetes and Heart Failure.ts
• | Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts
• | Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts
• | Dissecting the Data Discussions on the Management of SCAD.ts
• | Doorways To The Heart Valves In Systemic Disease.ts
• | Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts
• | ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts
• | Electrical Disorders – Rhythm and Conduction Disorders.ts
• | Emerging Technologies in Vascular Disease.ts
• | Endovascular Skills Basics to Bailout Techniques.ts
• | EP Issues in Cancer Patients – Beyond Heart Failure.ts
• | Essential Vascular Pearls for the Cardiovascular Clinician.ts
• | Essentials of Atrial Fibrillation Management – Learn From the Experts.ts
• | Evolution of Aortic Valve Replacement in Low-Risk Patients.ts
• | Expanding Frontiers in Vascular Intervention.ts
• | Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts
• | Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts
• | Featured Clinical Research I.ts
• | Featured Clinical Research II.ts
• | Featured Clinical Research III.ts
• | Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts
• | Fellows Bootcamp Structural.ts
• | FIT Forum Stump the Professor.ts
• | FIT Jeopardy Battle of the State Chapters Finals.ts
• | Focus on Interventional Complications.ts
• | Four Models of Myocardial Disease & Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts
• | From Controversy to Clarity in Weight Loss Therapies.ts
• | Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts
• | Gender-Specific Care of Patients with Acute Coronary Syndrome.ts
• | Genetics through Geriatrics – CV Prevention Through the Lifespan.ts
• | Getting to the Root of Dietary Effects.ts
• | Getting Your Life-and-Style Back in CVD.ts
• | Global Burden of Cardiovascular Disease in Women.ts
• | Global Leadership and Professional Education in the COVID-19 Era.ts
• | Great Debates in Vascular Medicine.ts
• | Harnessing the Power of Technology Remote Monitoring and Management in HF.ts
• | Help LDL.ts
• | Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts
• | Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts
• | Hemodynamics of Heart Failure You Thought You Knew Them.ts
• | Heterotaxy Syndrome or Somerism Whose Side Are You On.ts
• | Highlighted Original Research Electrophysiology and the Year in Review.ts
• | Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts
• | Highlighted Original Research Interventional and Structural and the Year in Review.ts
• | Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts
• | Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts
• | Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts
• | Highlighted Original Research Valvular Heart Disease and the Year in Review.ts
• | Highlighted Original Research Vascular Medicine and the Year in Review.ts
• | Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts
• | How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts
• | How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts
• | How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts
• | How to be an Effective Mentor & Mentee.ts
• | How to Become a Successful Researcher at Every Stage of Your Career.ts
• | How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts
• | How to Deal With Cases That Go From No Problem to Nightmare.ts
• | How to Stent a LM Like a Boss Left Main PCI Workshop.ts
• | Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts
• | Hypertension Management A Future Full of Promises.ts
• | I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts
• | Imagination is Everything Innovations in the Cath Lab.ts
• | Imaging Cardiomyopathies Challenging Cases.ts
• | Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts
• | Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts
• | Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts
• | Indirect Valvular Heart Disease Problems and Perspectives.ts
• | Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts
• | Insight of BAV Disease from Asia and Western Perspectives.ts
• | International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts
• | Interventional Challenging Cases II An Interventional & SHD Potpourri Not to Miss.ts
• | Interventional Challenging Cases Will Make You Think.ts
• | Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts
• | Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts
• | Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts
• | Jeopardy.ts
• | Journey of the Right Ventricle in Pulmonary Hypertension.ts
• | Kick Starting Your Research Career.ts
• | Late-Breaking Clinical Trials IV.ts
• | Late-Breaking Clinical Trials.ts
• | Launching a Successful Career in Academic Cardiology Key Points to Success.ts
• | Left Atrial Appendage Occlusion Clinical Challenges.ts
• | Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts
• | Let’s Get Physical! Exercise and Cardiovascular Health.ts
• | Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts
• | Living in 3D.ts
• | Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts
• | Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts
• | Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts
• | Managing Today’s Advanced Heart Failure Patient.ts
• | Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts
• | Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts
• | MINOCA A Show and Tell With the Experts.ts
• | Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts
• | Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts
• | Mobile ECG Monitoring How Can We Utilize Wearable Data.ts
• | Multimodality Cardiac Imaging and Modern Media.ts
• | Multimodality Imaging in Cardio-Oncology.ts
• | Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts
• | Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts
• | Must Know Tips for Publishing in JACC Journals.ts
• | Myocarditis and Heart Failure.ts
• | New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts
• | New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts
• | New Hypertension Therapies in Asian People.ts
• | New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts
• | New Recommendations on How to Monitor Patients Post TAVRSAVR.ts
• | Nuts & Bolts of Pregnancy and Congenital Heart Disease.ts
• | Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts
• | Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts
• | Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts
• | Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts
• | Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts
• | Parenteral Antithrombotic Therapies for ACS and PCI.ts
• | PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts
• | Perlas practicas en manejo de lipidos.ts
• | Perspectives on Pulmonary Hypertension.ts
• | Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts
• | Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts
• | Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts
• | Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts
• | Pharmacotherapy Considerations in Cardio-Obstetrics.ts
• | Polite Parlays in Pulmonary Hypertension.ts
• | Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts
• | Practical Pearls on ASCVD and Lipid Management.ts
• | Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts
• | Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts
• | Precision PCI in the Real World What Do I Use Every Day.ts
• | Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts
• | Professional Advancement Across the Academic Cardiology Life Course.ts
• | Professionalism and Ethics in Cardiology.ts
• | Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts
• | Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts
• | Pulmonary Hypertension Primer WHO Are the Groups.ts
• | Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts
• | Rapid Fire Session on Valvular Heart Disease.ts
• | Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts
• | Recent Trials in SIHD Translating Results into Clinical Practice.ts
• | Registries in Cardiac Imaging How Will they Change Clinical Practice.ts
• | Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts
• | Return To Play What The Experts Would Do.ts
• | Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts
• | Right Sided Valve Interventions.ts
• | Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts
• | Sex Differences in Arrhythmias.ts
• | Shock Teams and Shock Docs.ts
• | So You Want To Be a Chief of Cardiology.ts
• | Star Wars What Does the Future Hold for EP.ts
• | Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts
• | Strategies for Bleeding Avoidance After Complex PCI.ts
• | Streamlining diagnosis and treatment in chronic coronary artery disease.ts
• | Stress Echo Beyond Obstructive CAD.ts
• | Stroke Prophylaxis Treating the Untreated.ts
• | Structural Complications & How to Deal with Them.ts
• | Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts
• | Tackling Cardiometabolic Risk A Case Based Discussion.ts
• | The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts
• | The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts
• | The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts
• | The European Heart Journal’s Year in Cardiovascular Medicine.ts
• | The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4
• | The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4
• | The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4
• | The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4
• | The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4
• | The Future of Dyslipidemia Management.ts
• | The TeleHealth Cardiac Team Challenges and Opportunities.ts
• | The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts
• | The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts
• | Thrombosis & Prevention in COVID-19 What Are We Missing.ts
• | To Right a Wrong in Heart Failure.ts
• | Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts
• | Topical Topics in Pulmonary Arterial Hypertension.ts
• | Tough Choices Cases in Cardiogenic Shock.ts
• | Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4
• | Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4
• | Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4
• | Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4
• | Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts
• | Translational Cardiac Anatomy.ts
• | Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts
• | Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts
• | Tricuspid Regurgitation No Longer The Forgotten Valve.ts
• | Under the Bright Light Debates in Interventional Cardiology.ts
• | Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts
• | Unfolding the Mysteries of Cardiac Amyloidosis.ts
• | Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts
• | Universal Definition of Heart Failure.ts
• | Updates in Management of Hypertrophic Cardiomyopathy.ts
• | Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts
• | Valvular Conundrums Grey Area Cases, What the Experts Think.ts
• | VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts
• | Vascular Manifestations of COVID-19 Around the Globe.ts
• | Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts
• | Venous Interventions 2021.ts
• | Venous Thromboembolism Current Controversies and Practical Management.ts
• | Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts
• | Vulnerable Plaques Intervention or Pharmacologic Therapy.ts
• | Watchman Transmission.ts
• | What Can We Learn From Each Other For Global Heart Failure Care.ts
• | What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts
• | What’s In a Name Practicalities of the 4th Universal Definition of MI.ts
• | What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4
• | What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4
• | What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4
• | What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4
• | What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4
• | When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts
• | Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts
• | World Heart Federation Featured Research With Year in Review.ts
• | Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts
• | Your PVI Toolkit.ts